Skip to content

Safety and Efficacy of GPOEM in the Treatment of Gastroparesis

Safety and Efficacy of GPOEM in the Treatment of Gastroparesis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04349670
Enrollment
40
Registered
2020-04-16
Start date
2020-06-01
Completion date
2025-04-01
Last updated
2020-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroparesis, Gastroparesis Postoperative, Gastroparesis With Diabetes Mellitus

Keywords

GPOEM, gastroparesis, pyloromyotomy

Brief summary

The purpose of this study is to assess the clinical efficacy and safety in the treatment of gastroparesis.

Detailed description

After being informed about the data collected, all the patients affected with gastroparesis undergoing Gastric Per-Oral Endoscopic Myotomy (GPOEM) will be included in the observational protocol. Data concerning pre-operative symptoms and results of the imaging studies will be recorded together with operative time and operative complications. Patients will undergo periodical clinical consults and gastric emptying scintigraphy to assess the improvement in the symptoms and gastric motility.

Interventions

PROCEDUREGPOEM - gastric per-oral endoscopic myotomy

Endoscopic section of the pyloric muscle with submucosal tunnel technique.

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Gastroparesis (GCSI \> 2 OR Gastric emptying half-time \> 180 min OR gastric retention at 120 min \> 60% OR good response to botulinum if former criteria not met)

Exclusion criteria

* Age \< 18 years * Inability to understand protocol

Design outcomes

Primary

MeasureTime frameDescription
Clinical efficacy1, 3, 6, 12, 24 monthsChange in symptomatological scores
Functional efficacy3, 12, 24 monthsChange of scintigraphy evaluated gastric emptying time
Complicationsperi-operative time (48 hours)Evaluation of the operative adverse events

Secondary

MeasureTime frameDescription
Correlation of symptoms3, 12, 24 monthsEvaluate the correlation between symptoms and gastric emptying

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026